Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares Outstanding
Ratios

Tandem Diabetes Care (TNDM) Other Gross PP&E Adjustments (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Other Gross PP&E Adjustments readings, the most recent being $60.5 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 8.59% to $60.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $60.5 million, a 8.59% increase, with the full-year FY2025 number at $60.5 million, up 8.59% from a year prior.
  • Other Gross PP&E Adjustments hit $60.5 million in Q4 2025 for Tandem Diabetes Care, up from -$98.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $72.1 million in Q4 2021 to a low of -$126.7 million in Q2 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$88.3 million (2024), compared with a mean of -$51.5 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 1249.23% in 2021 and later skyrocketed 194.62% in 2023.
  • Tandem Diabetes Care's Other Gross PP&E Adjustments stood at $72.1 million in 2021, then tumbled by 80.43% to $14.1 million in 2022, then skyrocketed by 194.62% to $41.5 million in 2023, then skyrocketed by 34.0% to $55.7 million in 2024, then rose by 8.59% to $60.5 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $60.5 million (Q4 2025), -$98.4 million (Q3 2025), and -$98.4 million (Q2 2025) per Business Quant data.